Insider trade

Hims & Hers Health (HIMS): CEO sold ~$3.29M

Andrew Dudum, CEO at Hims & Hers Health, sold ~$3.29M of Hims & Hers Health shares.

~$3.29M
Approx. value · 65K sh @ $50.57
95K
Holds after · shares reported
Traded
Sep 17, 2025
Filed
Sep 19, 2025

What stands out in this filing

  • The sale was 40.6% of the shares this insider held before it; the filing reports 95,315 shares afterwards.
  • 65,110 shares at an average of $50.57 each, as reported on the form.
  • Footnote references a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 21, 2025Insider · 1 personInsiders: 4 sales (~$6.2M)
  2. Jul 23, 2025InsiderOfficer sold ~$770K of HIMS shares in the open market
  3. Jul 24, 2025InsiderOfficer sold ~$121K of HIMS shares in the open market
  4. Jul 28, 2025InsiderOfficer sold ~$151K of HIMS shares in the open market
  5. Jul 31, 2025InsiderOfficer sold ~$1.77M of HIMS shares in the open market
  6. Aug 1, 2025InsiderOfficer sold ~$16K of HIMS shares in the open market
  7. Aug 4, 2025CongressDisclosed purchase of HIMS — reported range $1,001 - $15,000
  8. Aug 6, 2025InsiderDirector sold ~$3.21M of HIMS shares in the open market
  9. Aug 7, 2025InsiderCEO sold ~$33.4M of HIMS shares in the open market
  10. Aug 11, 2025InsiderOfficer sold ~$133K of HIMS shares in the open market
  11. Aug 13, 2025InsiderCFO sold ~$556K of HIMS shares in the open market
  12. Aug 18, 2025Insider · 1 personInsiders: 6 sales (~$7.9M)
  13. Aug 25, 2025InsiderOfficer sold ~$114K of HIMS shares in the open market
  14. Aug 26, 2025InsiderCFO sold ~$506K of HIMS shares in the open market
  15. Sep 1, 2025Company filing · Form 8-K · Material agreementSigned an important agreement
  16. Sep 15, 2025Insider · 2 peopleInsiders: 3 sales (~$8.3M)
  17. Sep 16, 2025Insider · 1 personInsiders: 9 sales (~$9.4M)
  18. Sep 17, 2025 · this disclosureInsiderCEO sold ~$3.29M of HIMS shares in the open market

What came next

  1. Sep 17, 2025Insider · 4 peopleInsiders: 4 sales (~$1.8M)
  2. Sep 22, 2025InsiderCFO sold ~$1.36M of HIMS shares in the open market
  3. Sep 24, 2025InsiderOfficer sold ~$119K of HIMS shares in the open market
  4. Sep 28, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 28, 2025, Nader Kabbani, the Chief Operating Officer of Hims & Hers Health, Inc. (the “Company”) determined to step into a new advisory role for the Company effective November 2, 2025 (the “Transition Date”), where he will continue to provide ongoing strategic guidance to the Company and support for special global initiatives through July 2026.”
  5. Sep 29, 2025Insider · 2 peopleInsiders: 2 sales (~$5.3M)
  6. Oct 3, 2025InsiderCFO sold ~$669K of HIMS shares in the open market
  7. Oct 10, 2025InsiderOfficer sold ~$52K of HIMS shares in the open market
  8. Oct 13, 2025InsiderOfficer sold ~$143K of HIMS shares in the open market
  9. Oct 16, 2025Insider · 1 personInsiders: 9 sales (~$11.0M)
  10. Oct 17, 2025InsiderCFO sold ~$662K of HIMS shares in the open market
  11. Oct 27, 2025InsiderOfficer sold ~$132K of HIMS shares in the open market
  12. Nov 3, 2025Company filing · Form 8-K · ResultsReported its results
  13. Nov 10, 2025InsiderOfficer sold ~$112K of HIMS shares in the open market
  14. Nov 17, 2025InsiderCFO sold ~$853K of HIMS shares in the open market
  15. Nov 24, 2025InsiderOfficer sold ~$93K of HIMS shares in the open market
  16. Dec 9, 2025InsiderDirector sold ~$98K of HIMS shares in the open market
  17. Dec 17, 2025Insider · 4 peopleInsiders: 4 sales (~$1.4M)
  18. Dec 22, 2025InsiderCFO sold ~$825K of HIMS shares in the open market
  19. Jan 5, 2026InsiderCFO sold ~$306K of HIMS shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Hims & Hers Health

For Hims & Hers Health, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HIMS page.

Other recent filings by Andrew Dudum, Chief Executive Officer

The full history of Andrew Dudum, Chief Executive Officer is on the profile page.

How this filing works

Explore the data

Common questions

Which Hims & Hers Health (HIMS) insider traded, and how much?

Andrew Dudum, CEO at Hims & Hers Health, sold ~$3.29M of Hims & Hers Health shares. 65K shares at $50.57.

When did it happen, and when was it made public?

Traded: Sep 17, 2025. Filed: Sep 19, 2025. That is 2 days between the two dates.

What stands out in this filing?

The sale was 40.6% of the shares this insider held before it; the filing reports 95,315 shares afterwards. 65,110 shares at an average of $50.57 each, as reported on the form. Footnote references a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Hims & Hers Health recently?

For Hims & Hers Health, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the HIMS page.

Does this mean HIMS stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Hims & Hers Health

Everything OQRO holds on this company is on its HIMS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data